Evidence map›Paper›PMID 33892737›Full record

ArticleJournal of nanobiotechnology2021

Immunoengineered magnetic-quantum dot nanobead system for the isolation and detection of circulating tumor cells.

Pengfei Zhang, Mohamed S Draz, Anwen Xiong, Wannian Yan, Huanxing Han, Wansheng Chen

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Pengfei Zhang *Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China.ORCID http://orcid.org/0000-0001-6395-5750
Mohamed S Draz *Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.
Anwen Xiong *Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, China.
Wannian YanDepartment of Central Laboratory, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, 200443, China.
Huanxing HanDepartment of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China. huanxing_han@163.com.
Wansheng ChenDepartment of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China. chenwansheng@smmu.edu.cn.
Tongji University · CNSecond Military Medical University · CNHarvard University · US

Funding

International Science and Technology Cooperation Programme 2014DFA33010Science and Technology Commission of Shanghai Municipality 19441904200Science and Technology Commission of Shanghai Municipality 20S31902800Science and Technology Commission of Shanghai Municipality AI/RD2017-02
6 · The paper itself

Abstract

backgroundHighly efficient capture and detection of circulating tumor cells (CTCs) remain elusive mainly because of their extremely low concentration in patients' peripheral blood.

methodsWe present an approach for the simultaneous capturing, isolation, and detection of CTCs using an immuno-fluorescent magnetic nanobead system (iFMNS) coated with a monoclonal anti-EpCAM antibody.

resultsThe developed antibody nanobead system allows magnetic isolation and fluorescent-based quantification of CTCs. The expression of EpCAM on the surface of captured CTCs could be directly visualized without additional immune-fluorescent labeling. Our approach is shown to result in a 70-95% capture efficiency of CTCs, and 95% of the captured cells remain viable. Using our approach, the isolated cells could be directly used for culture, reverse transcription-polymerase chain reaction (RT-PCR), and immunocytochemistry (ICC) identification. We applied iFMNS for testing CTCs in peripheral blood samples from a lung cancer patient.

conclusionsIt is suggested that our iFMNS approach would be a promising tool for CTCs enrichment and detection in one step.

Indexed as

AntibodiesAntigens, NeoplasmCell Line, TumorCell SeparationEpithelial Cell Adhesion MoleculeFluorescent DyesHumansMagneticsMagnetite NanoparticlesMaleatesNanotechnologyNeoplastic Cells, CirculatingParticle SizePolystyrenesQuantum DotsAntibodiesAntigens, NeoplasmEPCAM protein, humanEpithelial Cell Adhesion MoleculeFluorescent DyesMagnetite NanoparticlesMaleatespoly(styrene-co-maleic anhydride)PolystyrenesCirculating tumor cellsFluorescent magnetic nanobeadsMagnetic nanoparticleQuantum dotsSimultaneous capture and detection

Identifiers

PMID33892737
PMCPMC8063296
OpenAlexW3126369279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.